IL-28A/IFN-lambda 2 Protein 8417-IL-025/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemIL-28A/IFN-lambda 2 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $408.00Supplier Page View Company Product Page
Catalog Number8417-IL-025/CF
Size25 ug
SpeciesHuman
Molecule NameIL-28A/IFN-lambda 2
Source/Expression SystemHEK293-derived Recombinant Human IL-28A/IFN-lambda 2 (HEK293) Protein, CF
NCBI Full Gene Nameinterferon lambda 2
NCBI Gene AliasesIFNL2a, IL28A, IFNL3a, IL-28A
FormatLyophilized from a 0.2 µm filtered solution in PBS
Purity>95%, by SDS-PAGE with silver staining
ApplicationsBioactivity
Conjugate/TagUnconjugated
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Specifications/Features

Available conjugates: Sizes Available: 25 ug

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) CD4 T-cell platform for delivering interferons as an antiviral countermeasure with a focus on SARS-CoV-2Mol MedMarch 28, 2026Xiaohe Liu, Marvin A. Ssemadaali, Harikrishnan Radhakrishnan, Juan Arredondo, Harold S. Javitz, Satya Dandekar, Parijat Bhatnagarproteins from R&D systems (IFN-β [Cat# 8499-IF-010/CF], IFN-λ1 [Cat# 1598-IL-025/CF], IFN-λ2 [Cat# 8417-IL-025/CF]) and IFN-α2 from InvivoGen [Cat# rcyc-hifna2b] were used as controls. RNA preparations used Direct-zol

(2) LRRC15 inhibits SARS-CoV-2 cellular entry in transPLoS biologyOctober 1, 2022Song J, Chow RD, Peña-Hernández MA, Zhang L, Loeb SA, So EY, Liang OD, Ren P, Chen S, Wilen CB, et al.plated per well. The following day, Universal IFN-I (R&D Systems, #11200–1) or IFN-λ2 (R&D Systems, #8417-IL-025/CF) was added at 100 U/mL or 100 ng/mL, respectively, and incubated at 37°C, 5% CO2. After 6-h incubation,

(3) LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in transbioRxiv : the preprint server for biologyNovember 24, 2021Song J, Chow RD, Pena-Hernandez M, Zhang L, Loeb SA, So EY, Liang OD, Wilen CB, Lee S.24-well plates. The following day, Universal IFN-I (R&D systems, #11200–1) or IFN-λ2 (R&D systems, #8417-IL-025/CF), was added at 100 U/mL or 100 ng/mL, respectively, and incubated at 37°C, 5% CO2. After 6-h incubation,

(4) Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potencyCytokineJanuary 1, 2020Chung JH, Hong SH, Seo N, Kim TS, An HJ, Lee P, Shin EC, Kim HM.

(5) IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN SignalingJournal of immunology (Baltimore, Md. : 1950)December 1, 2017Obajemu AA, Rao N, Dilley KA, Vargas JM, Sheikh F, Donnelly RP, Shabman RS, Meissner EG, Prokunina-Olsson L, Onabajo OO.

Be the First to Write a Review!

IL-28A/IFN-lambda 2 Protein from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (5)

Reviews

IL-28A/IFN-lambda 2 Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map